Tuesday, November 17, 2026 | 10:00-10:20 AM PT

Pharma & Life Sciences Zone Stage

The "average patient" is a pharmaceutical fiction. As GLP-1s and peptides reshape demand, the limits of one-size-fits-all medicine are increasingly clear. Patients vary in dose requirements, tolerances, allergies, budgets, and clinical responses. Shaun Noorian, Founder and CEO of Empower Pharmacy, will explore how personalized medicine corrects for a system built around the average patient instead of the one in front of the provider. He'll examine how established therapies can be adapted to individual patient needs in appropriate clinical circumstances, without losing the standards that make that safe to do at scale. The conversation will look at how the industry can draw a clearer line between mass-marketed products and legitimate patient-specific medicine, while maintaining quality, accountability, and patient safety. With experience operating both a 503A pharmacy and an FDA-registered 503B outsourcing facility with a national service footprint, Noorian will offer a practical perspective on growing personalized medicine responsibly.